EIF4A3 and hepatocellular carcinoma: Indeed, the expression of these elements, especially EIF4A3, was associated with key clinical and aggressiveness parameters and, most importantly, with patient overall recurrence and survival, suggesting a putative implication of the dysregulations of the splicing machinery and the development and progression of HCC.